reports
Solvay publishes notice of 2026 Annual General Meeting
Solvay publishes notice of 2026 Annual General Meeting Press release Regulated information Brussels, April 9, 2026, 5:45pm CEST Solvay today published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May 12, 2026 at the Event Lounge Conference Center, Boulevard Général Wahis 16/F, 1030 Brussels, at 10.30 am CEST. All documents relating to this meeting are now available on . Shareholders will be asked to vote on a number of resolutions, among others: the approval of the financial statements for the financial year 2025;the approval of a...
Solvay publie la convocation à son Assemblée Générale annuelle de 2026
Solvay publie la convocation à son Assemblée Générale annuelle de 2026 Communiqué de presse Information réglementée Bruxelles, le 9 avril 2026 - 17h45 CEST Solvay a publié aujourd'hui les documents relatifs à sa prochaine Assemblée Générale Ordinaire, qui se tiendra le mardi 12 mai 2026 à 10h30 CEST à l’Event Lounge Conference Center situé Boulevard Général Wahis 16/F, 1030 Bruxelles. Tous les documents relatifs à cette assemblée sont désormais disponibles sur . Les actionnaires seront invités à voter sur un certain ...
Solvay publiceert oproep tot Algemene Vergadering van 2026
Solvay publiceert oproep tot Algemene Vergadering van 2026 Persbericht Gereglementeerde informatie Brussel, 9 april 2026 - 17u45 CEST Solvay heeft vandaag de documenten voor zijn volgende Gewone Algemene Vergadering gepubliceerd. Deze zal plaatsvinden op dinsdag 12 mei 2026 in het Event Lounge Conference Center, Generaal Wahislaan 16/F, 1030 Brussel, om 10.30 uur CEST. Alle documenten met betrekking tot deze vergadering zijn nu beschikbaar op . De aandeelhouders zullen worden gevraagd te stemmen over een aantal resoluties, wa...
- Julian Dobrovolschi
- ING Helpdesk
Benelux Morning Notes
Euronext: Unsurprisingly strong quarter. Fagron: Somewhat softer 1Q26 expected, FY guidance maintained. Randstad: Preview 1Q26F results due 22 April; consensus released. Staffing: French staffing: February touch softer but March outlook better. Theon International: Teaming up with Rheinmetall
- Julian Dobrovolschi
- Julian Dobrovolschi
Euronext announces volumes for March 2026
Euronext announces volumes for March 2026 Euronext announces volumes for March 2026 Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 8 April 2026 – Euronext, the leading European capital market infrastructure, today announced trading volumes for March 2026. Monthly and historical volume tables are available at this address: CONTACTS ANALYSTS & INVESTORS – Investor Relations Judith Stein 97 Margaux Kurver 03 MEDIA – Europe Andrea Monzani 13 Sandra Machado 7 Belgium Marianne A...
Convening of the Annual General Meeting of Euronext N.V.
Convening of the Annual General Meeting of Euronext N.V. Convening of the Annual General Meeting of Euronext N.V. Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 7 April 2026 – Euronext today announced that the Annual General Meeting (“AGM”) will take place on Wednesday 20 May 2026 at 10.30 CEST at Beursplein 5, 1012 JW Amsterdam, The Netherlands. The agenda for the meeting is as follows: 1. Opening 2. Presentation by the Chief Executive Officer (discussion item)3. Annual Report 2025a) Explanation of the policy on additions to reserves and dividends (discussi...
Euronext publishes its detailed dividend payment schedule for 2026
Euronext publishes its detailed dividend payment schedule for 2026 Euronext publishes its detailed dividend payment schedule for 2026 Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 7 April 2026 – In line with the dividend distribution policy of Euronext, it is proposed to distribute 50% of 2025 reported net profit. As a consequence and subject to approval of shareholders at the Company’s Annual General Meeting to be held on 20 May 2026, the annual gross dividend on the 2025 results to be paid in 2026 amounts to €321.5 million, corresponding to a dividend per s...
Participation notifications by Citigroup Inc.
Participation notifications by Citigroup Inc. Press release Regulated information Brussels, April 3, 2026, 17:45 CEST In line with Belgian transparency legislation (Law of May 2, 2007), Citigroup Inc. recently sent to Solvay the following transparency notifications indicating that they crossed the threshold of 3%. Here is a summary of the notifications: Date on which the threshold is crossedVoting rights after the transactionEquivalent financial instruments after the transactionTotalMarch 26, 20260.29%2.71%3.00%March 27, 20...
Notifications de participation par Citigroup Inc.
Notifications de participation par Citigroup Inc. Communiqué de presse Information réglementée Bruxelles, le 3 avril 2026 - 17h45 CEST Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), Citigroup Inc. a envoyé récemment à Solvay les notifications de transparence suivantes indiquant avoir franchi le seuil de 3%. Voici un résumé des notifications: Date de dépassement de seuilDroits de voteInstruments financiers équivalentsTotal26 mars 20260,29%2,71%3,00%27 mars 20260,00%0,00%0,0...
Participatiemeldingen van Citigroup Inc.
Participatiemeldingen van Citigroup Inc. Persbericht Gereglementeerde informatie Brussel, 3 april 2026 - 17u45 CEST In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft Citigroup Inc. onlangs de volgende transparantiekennisgevingen naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden. Hier is een samenvatting van de bewegingen: Datum waarop de drempel werd overschredenStemrechtenAan stemrechten gelijkgestelde financiële instrumentenTotaal26 maart 20260,29%2,71%3,00%27 ma...
- Jacob Mekhael
Galapagos Signs agreement with Gilead on T-cell Engager in autoimmune ...
Galapagos announced that, following Gilead entering into a definitive agreement to acquire Ouro Medicines for $1,675m in cash consideration, and up to $500m in contingent milestone payments, Galapagos and Gilead have now entered into a binding agreement to collaborate on advancing gamgertamig (BCMAxCD3 T cell engager) in autoimmune diseases. This agreement comes after the companies announced their advanced discussions on the collaboration last week. Economically, Galapagos is effectively co-fina...
- Guy Sips
- Jacob Mekhael
- Mathijs Geerts Danau
- Wim Lewi
Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerkin...
Galapagos en Gilead gaan definitieve overeenkomst aan over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen De nieuwe samenwerkingsstructuur levert aanzienlijk verbeterde financiële voorwaarden en flexibiliteit voor Galapagos op Na deze transactie blijft de Vennootschap over het grootste deel van haar liquide middelen beschikken voor bijkomende strategische transacties en andere prioriteiten van kapitaalallocatie Kans om met gamgertamig een potentieel first-in-class & best-in-class T-cell-engager in auto-immuunziekten te ontwikkelen ...
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Ad...
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue to have a majority of its cash remaining for additional strategic transactions and other capital allocation priorities Opportunity to develop a potential first-in-class & best-in-class T cell engager in autoimmune diseases with gamgertamig Management to host conference call today, March 31, 20...
Euronext publishes its 2025 Universal Registration Document
Euronext publishes its 2025 Universal Registration Document Euronext publishes its 2025 Universal Registration Document Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 27 March 2026 – Euronext today announced that it has filed its 2025 Universal Registration Document, prepared in ESEF format (European Single Electronic Format), including the 2025 Annual Financial Statements and Directors’ Report to the Stichting Autoriteit Financiële Markten (the “AFM”), on 27 March 2026, as competent authority under Regulation (EU) 2017/1129. The 2025 Universal Registration Document ...
Galapagos Announces Nomination of Gino Santini to its Board of Directo...
Galapagos Announces Nomination of Gino Santini to its Board of Directors Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine Mr. Santini will bring extensive corporate governance, business development and industry leadership experience to the Board Mechelen, Belgium; March 26, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the proposed appointment of Gino Santini as a Non-Executive Independent Director, with the intention to appoint him as Chair of its Board of Directors, subject to shareholder...
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Ra...
Galapagos kondigt de voordracht aan van Gino Santini tot lid van de Raad van Bestuur De Raad van Bestuur is voornemens de heer Santini te benoemen tot Voorzitter, als opvolger van Jérôme Contamine, onder voorbehoud van zijn benoeming door aandeelhouders De heer Santini zal uitgebreide ervaring op het gebied van corporate governance, bedrijfsontwikkeling en leiderschap in de sector toevoegen aan de Raad van Bestuur Mechelen, België; 26 maart, 2026, 21:02 CET — Galapagos NV (Euronext & NASDAQ: GLPG), heeft vandaag bekendgemaakt dat Gino Santini is voorgedragen als Niet-Uitvoerend Onafhankel...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.